Following is an introduction to different divisions under Branded Strategic Business Unit (SBU) :
Magna is a multi-specialty division. It maps general practitioners, consulting physicians, surgeons, cardiologists, gastroenterologists, gynaecologists, paediatricians and nephrologists. Magna's portfolio primarily covers gastroenterology, cardiology, gynaecology and others. Magna's major brands are 'Aciloc', 'Rabeloc', 'Cadilose', 'Envas', 'Losium', 'Caditor', 'Calcirol', 'Haemup', 'LMX', 'LMX forte', Levocide, and 'Fludac'.
Maxima is a multispecialty division. Its portfolio covers respiratory inclusive of ENT, chest (anti tuberculosis), dentistry, anti-infectives and orthopaedic therapies. Maxima targets ENT specialists, chest physicians, dentists, paediatricians, orthopaedicians and surgeons. Major brands of this division are 'Lorfast', 'Vasograin', 'Symbiotik', 'Mycobutol', 'P-Zide', 'Amdepin', 'Emvit Plus', 'Cuga', and 'Immuvac'. 'Immuvac' is a unique immuno-modulator that has various applications including reducing duration of therapy for treatment of multi drug resistant tuberculosis, and multibacillary leprosy. The division also has certain superspecialty brands like 'Halonix' for orthopaedics.
A special task force for ophthalmology 'OTF' operates as a sub-unit of this division focusing on opthalmologists with brands like 'Scat', 'Loptame', 'Gatt', and 'Visial' among others.
Volta is a super-specialty division. Its portfolio covers cardiology, diabetology, endocrinology, gastroenterology, nephrology, and critical care. The division adopts three therapeutic approaches, viz., cardiac therapy, diabetic therapy, and critical therapy. Major brands of this division are 'Nodon', 'STPase', 'Teli', 'Envas IV', 'Glyloc', 'Glista', 'Caditor', 'Humstard'.
Oncocare division markets products that manage and treat cancer and tumours. Oncocare is expanding in haematology segment to emerge as a complete division providing medicines for treatment of solid tumour and haematological malignancies. Oncocare's major brands are 'Cadigran', 'Caditrex', 'Karplat', 'Paclicad', 'Posid', 'Kinaplat', 'Cadria L', 'Docecad', 'Filcad', 'Platin' and 'Recovarin'.
Magna XL division's objective is to increase reach and penetration in rural market. Magna XL aims to make available quality medicines at affordable prices to people living in interior towns and villages. Magna XL's portfolio covers general practitioners, consulting physicians, pediatricians, and gynaecologists. Magna XL's thrust brands are 'Nuflam', 'Haem up', 'Tummy Ease', 'Happytizer', 'Lactoceff', 'Anstisept', 'Hepasave', 'LMX', 'Wormin A', and 'Fleximuv'.
Generic is a wing of pharma business. The wing covers almost all therapeutic segments. Generic directly deals with stockists primarily, and retailers and dispensing doctors secondarily through super distributors. A major chunk of business and promotion focuses mainly on stockists. Generic has three sub divisions, namely, 'Generic', 'Genvista' and 'Genstar'. Generic's major brands are 'Ciprodac', 'DPhesic', 'Dexasone', 'Famonext', 'Demisone', 'Campicillin', 'Oritaxim Inj.', 'Mokcan' and 'Cotrimoxazole DS'.
Vetnova is animal healthcare division. It is one of the earliest and most reputed concerns in animal healthcare. At present Vetnova happens to be one of the fastest growing enterpises harnessing the opportunities across the market. A team of more than 100 people takes a wide range of our brands pertaining to cattle, poultry and canine into the remotest corners of India. While some of Vetnova's brands like 'Cal D Plus DS', 'Onfeed' and 'Cal D Min' are household names, other brands like 'Nolapse' (for prelapse) and 'Endotrin (Ecbolic)' are innovative offerings of Vetnova. The division is on the path to growth and intends to take its brands beyond the borders.